{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T01:49:56Z","timestamp":1769824196569,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012681","name":"Universit\u00e4tsklinikum K\u00f6ln","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012681","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Plasma cell dyscrasias (PCD) are characterized by an abnormal production of intact monoclonal immunoglobulins or parts such as heavy or light chains. In most cases, the monoclonal protein (also termed paraprotein) is produced by a clonal plasma cell population. The production of monoclonal proteins can result in deposits of various types and localization depending on the type, amount, and electrochemical properties of the paraprotein. One histopathologic presentation, albeit rare, are crystalline deposits. They can form in various organs and hence cause a wide spectrum of symptoms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 49-year-old man presented to the emergency department with eyestrain and foreign body sensation after overhead drilling. Examination of the eyes revealed crystalline deposits in the cornea of both eyes. After additional diagnostic testing, deposits were attributed to free light chains. Monoclonal gammopathy of undetermined significance (MGUS) was diagnosed according to serum electrophoresis and immunofixation. Four years later, new onset of proteinuria was detected. A percutaneous biopsy of the kidney showed severe light chain podocytopathy with secondary focal segmental glomerulosclerosis (FSGS) and light chain proximal tubulopathy (LCPT). In these lesions, crystalline deposits identical to the corneal deposits were found in ultrastructural and immunofluorescent analysis. The patient was diagnosed with monoclonal gammopathy of renal significance (MGRS), and a plasma cell directed therapy was initiated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>PCD can present with a wide array of symptoms and are notoriously difficult to diagnose. Extrarenal manifestations such as crystalline deposits in the cornea are one possible manifestation. The case presented herein emphasizes the notion that extrarenal paraprotein deposits warrant a thorough search for the underlying clonal disease.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12882-021-02309-x","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T19:03:01Z","timestamp":1617735781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Crystalline deposits in the cornea and various areas of the kidney as symptoms of an underlying monoclonal gammopathy: a case report"],"prefix":"10.1186","volume":"22","author":[{"given":"C.","family":"Lindemann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Enders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. T.","family":"Brinkkoetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4461-6128","authenticated-orcid":false,"given":"L. A.","family":"V\u00f6lker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,6]]},"reference":[{"issue":"6","key":"2309_CR1","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/leu.2010.60","volume":"24","author":"RA Kyle","year":"2010","unstructured":"Kyle RA, Durie BGM, Rajkumar SV, Landgren O, Blade J, Merlini G, et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia. 2010;24(6):1121\u20137. https:\/\/doi.org\/10.1038\/leu.2010.60.","journal-title":"Leukemia."},{"issue":"7","key":"2309_CR2","doi-asserted-by":"publisher","first-page":"859","DOI":"10.4065\/79.7.859","volume":"79","author":"RA Kyle","year":"2004","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Melton LJ. Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. Mayo Clin Proc. 2004;79(7):859\u201366. https:\/\/doi.org\/10.4065\/79.7.859.","journal-title":"Mayo Clin Proc"},{"issue":"13","key":"2309_CR3","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;354(13):1362\u20139. https:\/\/doi.org\/10.1056\/NEJMoa054494.","journal-title":"N Engl J Med"},{"issue":"5","key":"2309_CR4","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","volume":"121","author":"International Myeloma Working Group","year":"2003","unstructured":"International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the international myeloma working group. Br J Haematol. 2003;121(5):749\u201357. https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04355.x.","journal-title":"Br J Haematol"},{"issue":"1","key":"2309_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/leu.2008.291","volume":"23","author":"RA Kyle","year":"2009","unstructured":"Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia. 2009;23(1):3\u20139. https:\/\/doi.org\/10.1038\/leu.2008.291.","journal-title":"Leukemia."},{"issue":"12","key":"2309_CR6","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos M-V, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538\u201348. https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5.","journal-title":"Lancet Oncol"},{"issue":"33","key":"2309_CR7","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.1200\/JCO.2010.30.8791","volume":"28","author":"MA Dimopoulos","year":"2010","unstructured":"Dimopoulos MA, Terpos E, Chanan-Khan A, Leung N, Ludwig H, Jagannath S, et al. Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the international myeloma working group. J Clin Oncol. 2010;28(33):4976\u201384. https:\/\/doi.org\/10.1200\/JCO.2010.30.8791.","journal-title":"J Clin Oncol"},{"issue":"7","key":"2309_CR8","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1681\/ASN.V1271482","volume":"12","author":"J Lin","year":"2001","unstructured":"Lin J, Markowitz GS, Valeri AM, Kambham N, Sherman WH, Appel GB, et al. Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol. 2001;12(7):1482\u201392.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2309_CR9","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1001\/archopht.1959.00940090543007","volume":"61","author":"SB Aronson","year":"1959","unstructured":"Aronson SB, Shaw R. Corneal crystals in multiple myeloma. Arch Ophthalmol. 1959;61(4):541\u20136. https:\/\/doi.org\/10.1001\/archopht.1959.00940090543007.","journal-title":"Arch Ophthalmol"},{"issue":"22","key":"2309_CR10","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","volume":"120","author":"N Leung","year":"2012","unstructured":"Leung N, Bridoux F, Hutchison CA, Nasr SH, Cockwell P, Fermand J-P, et al. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood. 2012;120(22):4292\u20135. https:\/\/doi.org\/10.1182\/blood-2012-07-445304.","journal-title":"Blood."},{"issue":"4","key":"2309_CR11","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ki.2014.408","volume":"87","author":"F Bridoux","year":"2015","unstructured":"Bridoux F, Leung N, Hutchison CA, Touchard G, Sethi S, Fermand J-P, et al. Diagnosis of monoclonal gammopathy of renal significance. Kidney Int. 2015;87(4):698\u2013711. https:\/\/doi.org\/10.1038\/ki.2014.408.","journal-title":"Kidney Int"},{"issue":"5","key":"2309_CR12","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1681\/ASN.2015020185","volume":"27","author":"MB Stokes","year":"2016","unstructured":"Stokes MB, Valeri AM, Herlitz L, Khan AM, Siegel DS, Markowitz GS, et al. Light chain proximal Tubulopathy: clinical and pathologic characteristics in the modern treatment era. J Am Soc Nephrol. 2016;27(5):1555\u201365. https:\/\/doi.org\/10.1681\/ASN.2015020185.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2309_CR13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/sj.ki.5000144","volume":"69","author":"SH Nasr","year":"2006","unstructured":"Nasr SH, Preddie DC, Markowitz GS, Appel GB, D'Agati VD. Multiple myeloma, nephrotic syndrome and crystalloid inclusions in podocytes. Kidney Int. 2006;69(3):616\u201320. https:\/\/doi.org\/10.1038\/sj.ki.5000144.","journal-title":"Kidney Int"},{"issue":"8","key":"2309_CR14","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1182\/blood-2006-03-001164","volume":"108","author":"G Merlini","year":"2006","unstructured":"Merlini G, Stone MJ. Dangerous small B-cell clones. Blood. 2006;108(8):2520\u201330. https:\/\/doi.org\/10.1182\/blood-2006-03-001164.","journal-title":"Blood."},{"issue":"14","key":"2309_CR15","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1182\/blood-2018-04-839480","volume":"132","author":"J-P Fermand","year":"2018","unstructured":"Fermand J-P, Bridoux F, Dispenzieri A, Jaccard A, Kyle RA, Leung N, et al. Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications. Blood. 2018;132(14):1478\u201385. https:\/\/doi.org\/10.1182\/blood-2018-04-839480.","journal-title":"Blood."},{"key":"2309_CR16","doi-asserted-by":"publisher","unstructured":"Garibaldi DC, Gottsch J, La Cruz Z de, Haas M, Green WR. Immunotactoid keratopathy: a clinicopathologic case report and a review of reports of corneal involvement in systemic paraproteinemias. Surv Ophthalmol 2005;50:61\u201380. doi:https:\/\/doi.org\/10.1016\/j.survophthal.2004.10.002, 1.","DOI":"10.1016\/j.survophthal.2004.10.002"},{"issue":"6","key":"2309_CR17","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1167\/iovs.15-18594","volume":"57","author":"P Aragona","year":"2016","unstructured":"Aragona P, Allegra A, Postorino EI, Rania L, Innao V, Wylegala E, et al. Corneal structural changes in nonneoplastic and neoplastic monoclonal Gammopathies. Invest Ophthalmol Vis Sci. 2016;57(6):2657\u201365. https:\/\/doi.org\/10.1167\/iovs.15-18594.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"2309_CR18","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/ICO.0000000000001078","volume":"36","author":"P Enders","year":"2017","unstructured":"Enders P, Holtick U, Schaub F, Tuchscherer A, Hermann MM, Scheid C, et al. Corneal densitometry for quantification of corneal deposits in monoclonal Gammopathies. Cornea. 2017;36(4):470\u20135. https:\/\/doi.org\/10.1097\/ICO.0000000000001078.","journal-title":"Cornea."},{"issue":"3","key":"2309_CR19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.4065\/79.3.410","volume":"79","author":"R Kleta","year":"2004","unstructured":"Kleta R, Blair SC, Bernardini I, Kaiser-Kupfer MI, Gahl WA. Keratopathy of multiple myeloma masquerading as corneal crystals of ocular cystinosis. Mayo Clin Proc. 2004;79(3):410\u20132. https:\/\/doi.org\/10.4065\/79.3.410.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"2309_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","volume":"15","author":"N Leung","year":"2019","unstructured":"Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D'Agati VD, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the international kidney and monoclonal Gammopathy research group. Nat Rev Nephrol. 2019;15(1):45\u201359. https:\/\/doi.org\/10.1038\/s41581-018-0077-4.","journal-title":"Nat Rev Nephrol"},{"issue":"26","key":"2309_CR21","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJM199106273242603","volume":"324","author":"A Solomon","year":"1991","unstructured":"Solomon A, Weiss DT, Kattine AA. Nephrotoxic potential of Bence Jones proteins. N Engl J Med. 1991;324(26):1845\u201351. https:\/\/doi.org\/10.1056\/NEJM199106273242603.","journal-title":"N Engl J Med"},{"issue":"4","key":"2309_CR22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nrneph.2018.8","volume":"14","author":"C Sirac","year":"2018","unstructured":"Sirac C, Herrera GA, Sanders PW, Batuman V, Bender S, Ayala MV, et al. Animal models of monoclonal immunoglobulin-related renal diseases. Nat Rev Nephrol. 2018;14(4):246\u201364. https:\/\/doi.org\/10.1038\/nrneph.2018.8.","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"2309_CR23","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/his.12768","volume":"68","author":"R Kanagal-Shamanna","year":"2016","unstructured":"Kanagal-Shamanna R, Xu-Monette ZY, Miranda RN, Dogan A, Zou D, Luthra R, et al. Crystal-storing histiocytosis: a clinicopathological study of 13 cases. Histopathology. 2016;68(4):482\u201391. https:\/\/doi.org\/10.1111\/his.12768.","journal-title":"Histopathology."},{"issue":"1","key":"2309_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/leu.2016.195","volume":"31","author":"M Vignon","year":"2017","unstructured":"Vignon M, Javaugue V, Alexander MP, El-Karoui K, Karras A, Roos-Weil D, et al. Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients. Leukemia. 2017;31(1):123\u20139. https:\/\/doi.org\/10.1038\/leu.2016.195.","journal-title":"Leukemia."},{"issue":"3","key":"2309_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/00005792-200005000-00002","volume":"79","author":"T Messiaen","year":"2000","unstructured":"Messiaen T, Deret S, Mougenot B, Bridoux F, Dequiedt P, Dion JJ, et al. Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients. Medicine (Baltimore). 2000;79(3):135\u201354. https:\/\/doi.org\/10.1097\/00005792-200005000-00002.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"2309_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/MNH.0000000000000201","volume":"25","author":"S Sethi","year":"2016","unstructured":"Sethi S, Fervenza FC, Rajkumar SV. Spectrum of manifestations of monoclonal gammopathy-associated renal lesions. Curr Opin Nephrol Hypertens. 2016;25(2):127\u201337. https:\/\/doi.org\/10.1097\/MNH.0000000000000201.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"5","key":"2309_CR27","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.humpath.2012.10.012","volume":"44","author":"A Duquesne","year":"2013","unstructured":"Duquesne A, Werbrouck A, Fabiani B, Denoyer A, Cervera P, Verpont MC, et al. Complete remission of monoclonal gammopathy with ocular and periorbital crystal storing histiocytosis and Fanconi syndrome. Hum Pathol. 2013;44(5):927\u201333. https:\/\/doi.org\/10.1016\/j.humpath.2012.10.012.","journal-title":"Hum Pathol"},{"key":"2309_CR28","doi-asserted-by":"publisher","first-page":"e13638","DOI":"10.1097\/MD.0000000000013638","volume":"97","author":"I Boudhabhay","year":"2018","unstructured":"Boudhabhay I, Titah C, Talbot A, Harel S, Verine J, Touchard G, et al. Multiple myeloma with crystal-storing histiocytosis, crystalline podocytopathy, and light chain proximal tubulopathy, revealed by retinal abnormalities: A case report. Medicine (Baltimore). 2018;97:e13638. https:\/\/doi.org\/10.1097\/MD.0000000000013638.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"2309_CR29","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.3892\/ol.2015.3669","volume":"10","author":"Z-Y Dong","year":"2015","unstructured":"Dong Z-Y, Xing H-T, Wang Y-D, Zhang W, Qiu Q, Chen X-M. Multiple myeloma with a previous diagnosis of focal segmental glomerulosclerosis: a case report and review of the literature. Oncol Lett. 2015;10(5):2821\u20137. https:\/\/doi.org\/10.3892\/ol.2015.3669.","journal-title":"Oncol Lett"},{"key":"2309_CR30","doi-asserted-by":"publisher","first-page":"946","DOI":"10.12659\/AJCR.909696","volume":"19","author":"AO Oweis","year":"2018","unstructured":"Oweis AO, Al Shelleh SA, Aldaoud N, Alshari OM, Al-Abbadi MA. Multiple Myeloma in a Patient with Focal Segmental Glomerulosclerosis: A Case Report. Am J Case Rep. 2018;19:946\u201350. https:\/\/doi.org\/10.12659\/AJCR.909696.","journal-title":"Am J Case Rep"},{"issue":"2","key":"2309_CR31","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1053\/j.ajkd.2005.05.004","volume":"46","author":"D Dingli","year":"2005","unstructured":"Dingli D, Larson DR, Plevak MF, Grande JP, Kyle RA. Focal and segmental glomerulosclerosis and plasma cell proliferative disorders. Am J Kidney Dis. 2005;46(2):278\u201382. https:\/\/doi.org\/10.1053\/j.ajkd.2005.05.004.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2309_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3109\/08820538.2012.730102","volume":"28","author":"I Paladini","year":"2013","unstructured":"Paladini I, Pieretti G, Giuntoli M, Abbruzzese G, Menchini U, Mencucci R. Crystalline corneal deposits in monoclonal gammopathy: in-vivo confocal microscopy. Semin Ophthalmol. 2013;28(1):37\u201340. https:\/\/doi.org\/10.3109\/08820538.2012.730102.","journal-title":"Semin Ophthalmol"},{"issue":"6","key":"2309_CR33","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/00003226-199911000-00018","volume":"18","author":"T Kato","year":"1999","unstructured":"Kato T, Nakayasu K, Omata Y, Watanabe Y, Kanai A. Corneal deposits as an alerting sign of monoclonal Gammopathy. Cornea. 1999;18(6):734\u20138. https:\/\/doi.org\/10.1097\/00003226-199911000-00018.","journal-title":"Cornea."},{"issue":"1","key":"2309_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1001\/archopht.118.1.125","volume":"118","author":"LP Schelonka","year":"2000","unstructured":"Schelonka LP. Acute unilateral corneal Immunoprotein deposition in IgM monoclonal Gammopathy. Arch Ophthalmol. 2000;118(1):125\u20136. https:\/\/doi.org\/10.1001\/archopht.118.1.125.","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"2309_CR35","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.ophtha.2015.05.029","volume":"122","author":"T Milman","year":"2015","unstructured":"Milman T, Kao AA, Chu D, Gorski M, Steiner A, Simon CZ, et al. Paraproteinemic Keratopathy: the expanding diversity of clinical and pathologic manifestations. Ophthalmology. 2015;122(9):1748\u201356. https:\/\/doi.org\/10.1016\/j.ophtha.2015.05.029.","journal-title":"Ophthalmology."}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02309-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-021-02309-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02309-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T06:24:40Z","timestamp":1619850280000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02309-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,6]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2309"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02309-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,6]]},"assertion":[{"value":"10 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Paul T. Brinkk\u00f6tter declares grants from the German Research Foundation (DFG BR2955\/8) and personal fees from Alexion, Bayer, Novartis, Pfizer, Sanofi-Genzyme, Travere Therapeutics, Vifor (speaker honoraria, advisory boards).LV has received advisory board and speaker honoraria from Sanofi-Genzyme.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}